Cadrobbi Julie, Hecq Jean-Daniel, Vanbeckbergen Danielle, Jamart Jacques, Galanti Laurence
Medical Laboratory, Cliniques Universitaires UCL Mont-Godinne, Belgium.
J Oncol Pharm Pract. 2007 Jun;13(2):99-103. doi: 10.1177/1078155207080118.
Preparation of intravenous solutions in advance could be an efficient approach to improve quality assurance, security, time management, and cost saving of drug provision. The purpose of this paper is to investigate the stability of sodium folinate solutions at 3.2 mg mL-1 in 5% dextrose polyolefin bags at 4degreesC.
The stability of five polyolefin bags of solution containing approximately 3.2 mg mL-1 of sodium folinate in 5% dextrose prepared under aseptic conditions and stored at 48degreesC have been studied over 30 days. Sodium folinate concentrations have been measured by high performance liquid chromatography and the results have been analysed by regression analysis. Solutions have been visually inspected and pH measured.
No colour change or precipitation occurred in the preparations. Based on a shelf-life of 90% residual potency, sodium folinate solutions have been observed to be stable for a period of at least 30 days at 4degreesC, where lower confidence limits of the results value remain above 90% of the initial concentration. During this stability period, the pH values of infusions have been observed to decrease slightly without affecting chromatographic parameters.
Within these limits, sodium folinate in 5% dextrose infusion may be prepared and stored in advance by a centralized intravenous admixture service.
提前配制静脉输液可能是提高药品供应质量保证、安全性、时间管理和成本节约的有效方法。本文旨在研究亚叶酸钙溶液在4℃下于5%葡萄糖聚烯烃袋中浓度为3.2mg/mL时的稳定性。
对在无菌条件下制备并储存于4℃的五袋含约3.2mg/mL亚叶酸钙的5%葡萄糖溶液进行了为期30天的稳定性研究。通过高效液相色谱法测定亚叶酸钙浓度,并通过回归分析对结果进行分析。对溶液进行了外观检查并测量了pH值。
制剂未出现颜色变化或沉淀。基于90%残留效期的有效期,观察到亚叶酸钙溶液在4℃下至少30天内稳定,结果值的较低置信限仍高于初始浓度的90%。在此稳定期内,观察到输液的pH值略有下降,但不影响色谱参数。
在这些限制范围内,5%葡萄糖输液中的亚叶酸钙可由集中式静脉药物配置服务提前配制和储存。